Optimi Health Corp. operates as a pharmaceutical and nutraceutical drug manufacturing company in Canada. The company manufactures controlled substances including finished MDMA and psilocybin drug products, supplying them directly to authorized clinics, pharmacies, clinical trials, and partners. The company produces and supplies MDMA, natural psilocybin, psilocin, other psychedelic substances, and functional mushrooms derived from botanical sources for health and wellness markets. The company also engages in farming, processing, and distribution of raw mushroom biomass, mushroom extracts, manufacturing of drug products, and mushroom supplements. It sells its products through Amazon marketplace and distributors/brokers, as well as online. Optimi Health Corp. was incorporated in 2020 and is based in Princeton, Canada.
Frequently asked questions
What sector does Optimi Health Corp (OPTI) operate in?
Optimi Health Corp belongs to the Consumer Staples sector and operates in the Drug Manufacturers - Specialty & Generic industry.
What is Optimi Health Corp (OPTI) current stock price?
As of the latest data, Optimi Health Corp stock price is CA$6.60, with a previous close of CA$6.55. Optimi Health Corp gained CA$0.05 in the last trading session, representing a 0.76% increase.
What is Optimi Health Corp (OPTI) current market capitalization?
Optimi Health Corp market cap is approximately 37.79 million.
What is Optimi Health Corp (OPTI) Earnings Per Share (EPS)?
The trailing EPS is -CA$1.72, and the forward EPS is -CA$0.64.
Does Optimi Health Corp (OPTI) pay dividends?
No. Optimi Health Corp does not pay a dividend.
How did Optimi Health Corp (OPTI) perform in its most recent earnings report?
In the last report (March 31, 2026), Optimi Health Corp posted an EPS surprise of -36.11% and a revenue surprise of -44.72%.
What is Optimi Health Corp (OPTI) beta (volatility) score?
Optimi Health Corp has a beta of 1.600, suggesting it is more volatile than the market.
